Abstract
526P In silico evaluation of the mutational profile of glioblastomas with high expression of PD1, CTLA4 and LAG3 identifies the ERBB-PI3K pathway as a druggable vulnerability target
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have